Riccardo Mazza։ Personalized Anticoagulation in Atrial Fibrillation
Riccardo Mazza, Cardiology Resident at University Vita-Salute San Raffaele, shared a post on LinkedIn about a recent article he co-authored with Cosmo Godino, adding:
՛՛Our response to the Letter to the Editor by Magdelijns et al. has been published in the Journal of Thrombosis and Haemostasis.
The concept of ‘one-size-fits-all’ anticoagulation may have limitations in contemporary AF management.
Personalized anticoagulation is progressively moving from theoretical consideration to clinical discussion.
We are grateful for the ongoing scientific discussion and look forward to the results of the DOAC-FRAIL trial.՛՛
Title: Plasma levels measurement of the 4 direct oral anticoagulants in patients with atrial fibrillation at the time of acute thromboembolic and bleeding events: reply
Authors: Cosmo Godino, Riccardo Mazza
Read the Full Article on Journal of Thrombosis and Haemostasis․
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 18, 2026, 15:26Beverlyn Anyango Polet: Bold Solutions for Maternal and Reproductive Health at the AYSRHR 2026
-
Feb 18, 2026, 15:24Peter Zdziarski: How Glanzmann Thrombasthenia Suddenly Became ‘Mainstream’?
-
Feb 18, 2026, 15:22Kanishk Kumar: Thalassemia Pipeline 2025 Addressing Hemoglobin Deficiencies in Inherited Blood Disorders
-
Feb 18, 2026, 15:18Veronica Sanchez: First-Ever Interventional Recommendations for Pediatric Acute Ischemic Stroke
-
Feb 18, 2026, 15:07Flora Peyvandi: The Evidence Gap in Drug Safety During Pregnancy
-
Feb 18, 2026, 14:44Omolade Awodu Awodu։ Charting a Sustainable Path for Inherited Blood Disorders in Nigeria
-
Feb 18, 2026, 14:34Vincent Ten Cate: FXI(a) and Its Links With Cardiovascular Disease
-
Feb 18, 2026, 14:30Mohamed Sikkander Abdul Razak: A Single Stem Cell Generating 14 Million Tumor-Killing NK Cells
-
Feb 18, 2026, 13:26Jecko Thachil: Are There More Than Anticoagulants for Venous Thromboembolism Prophylaxis?